The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Intelligence (AI) in Cancer Market Research Report 2025
Synopsis
Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
The global Artificial Intelligence (AI) in Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Artificial Intelligence (AI) in Cancer in Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Artificial Intelligence (AI) in Cancer include IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Cancer.
Report Scope
The Artificial Intelligence (AI) in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence (AI) in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.
The global Artificial Intelligence (AI) in Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Intelligence (AI) in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Artificial Intelligence (AI) in Cancer in Diagnosis is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Artificial Intelligence (AI) in Cancer include IBM, Microsoft, NVIDIA, Intel, GE Healthcare, Johnson & Johnson, Cancer Center.ai, Digital Reasoning and Varian Medical Systems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Cancer.
Report Scope
The Artificial Intelligence (AI) in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence (AI) in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI
Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy
Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2019-2030)
2.2 Artificial Intelligence (AI) in Cancer Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Cancer Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Size by Region (2019-2024)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Region (2025-2030)
2.3 Artificial Intelligence (AI) in Cancer Market Dynamics
2.3.1 Artificial Intelligence (AI) in Cancer Industry Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue (2019-2024)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2019-2024)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence (AI) in Cancer Revenue
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2023
3.5 Artificial Intelligence (AI) in Cancer Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence (AI) in Cancer Product Solution and Service
3.7 Date of Enter into Artificial Intelligence (AI) in Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2019-2024)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2025-2030)
5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2019-2024)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2019-2030)
6.2 North America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2019-2024)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2019-2030)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2019-2024)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size (2019-2030)
8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2019-2024)
8.4 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Cancer Market Size (2019-2030)
9.2 Latin America Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2019-2024)
9.4 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size (2019-2030)
10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2019-2024)
10.4 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.1.5 IBM Recent Development
11.2 Microsoft
11.2.1 Microsoft Company Detail
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.2.5 Microsoft Recent Development
11.3 NVIDIA
11.3.1 NVIDIA Company Detail
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.3.5 NVIDIA Recent Development
11.4 Intel
11.4.1 Intel Company Detail
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.6.5 Johnson & Johnson Recent Development
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Detail
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.7.5 Cancer Center.ai Recent Development
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Detail
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.8.5 Digital Reasoning Recent Development
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Detail
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.9.5 Varian Medical Systems Recent Development
11.10 Niramai
11.10.1 Niramai Company Detail
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.10.5 Niramai Recent Development
11.11 Densitas
11.11.1 Densitas Company Detail
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.11.5 Densitas Recent Development
11.12 MammoScreen
11.12.1 MammoScreen Company Detail
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.12.5 MammoScreen Recent Development
11.13 MVision AI
11.13.1 MVision AI Company Detail
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.13.5 MVision AI Recent Development
11.14 Volpara
11.14.1 Volpara Company Detail
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.14.5 Volpara Recent Development
11.15 LungLifeAI
11.15.1 LungLifeAI Company Detail
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2019-2024)
11.15.5 LungLifeAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
